Type 2 diabetes mellitus as an independent factor in the severe course of the new coronavirus infection (COVID-19) in obese patients
Open Access
- 27 July 2026
- journal article
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (6) , 352-358
Abstract
Aim. To study the role of type 2 diabetes mellitus (DM 2) as an independent factor in the severe course of COVID-19 in obese patients. Materials and methods. The data of 1414 obese people hospitalized with COVID-19 at University Clinical Hospital №4 of Sechenov First Moscow State Medical University (Sechenov University), were analyzed. Two groups were formed: group 1 – 256 obese people with DM 2, group 2 – 1158 obese people without DM 2. The severity of COVID-19 was assessed using standard laboratory and instrumental parameters. Death and intensive care unit admission (ICU) were selected as the primary endpoints. Results. Patients with DM 2 had higher markers of inflammation and coagulation. The volume of lung damage according to computed tomography in group 1 exceeded the indicators of group 2 – 40 (27,5; 61,25%) vs 37,5 (25; 45%); p0.05. The frequency of ICU admission and deaths in patients with DM 2 was higher (25 and 16.4%) compared with the indicators of group 2 (6.8 and 4.1%); p0.05. According to multivariate regression analysis, DM 2 was an independent factor associated with ICU admission (odds ratio 1.87, CI 1.14–3.06) and death (odds ratio 2.45, CI 1.35–4.45); p0.05. In patients with obesity and DM 2, CRP values of more than 107.8 and 125.7 mg/l have high prognostic value in relation to the risk of ICU admission and death. Conclusion. DM 2 is an independent factor in the severe course of COVID-19.Keywords
This publication has 19 references indexed in Scilit:
- Type 2 diabetes mellitus as a predictor of severe outcomes in COVID-19 — a systematic review and meta-analysesBMC Infectious Diseases, 2025
- HKU5-CoV-2: A silent threat looming in batsTravel Medicine and Infectious Disease, 2025
- Prevalence and impact of diabetes in hospitalized COVID‐19 patients: A systematic review and meta‐analysisJournal of Diabetes, 2021
- Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysisReviews in Endocrine and Metabolic Disorders, 2021
- Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetesCardiovascular Therapy and Prevention, 2021
- Fasting blood glucose level is a predictor of mortality in patients with COVID-19 independent of diabetes historyDiabetes Research and Clinical Practice, 2020
- The relationship between diabetes and clinical outcomes in COVID-19: a single-center retrospective analysisActa Diabetologica, 2020
- Diabetes mellitus type 2 in adultsDiabetes mellitus, 2020
- Platelet activity and hypercoagulation in type 2 diabetesCardiovascular Diabetology, 2018
- Type 2 diabetes as an inflammatory diseaseNature Reviews Immunology, 2011